Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Inventory (2020 - 2026)

Sotera Health has reported Inventory over the past 6 years, most recently at $54.4 million for Q4 2025.

  • For Q4 2025, Inventory rose 10.61% year-over-year to $54.4 million; the TTM value through Dec 2025 reached $54.4 million, up 10.61%, while the annual FY2025 figure was $54.4 million, 10.61% up from the prior year.
  • Inventory for Q4 2025 was $54.4 million at Sotera Health, up from $49.9 million in the prior quarter.
  • Over five years, Inventory peaked at $61.0 million in Q1 2025 and troughed at $33.4 million in Q1 2021.
  • A 5-year average of $46.6 million and a median of $47.5 million in 2023 define the central range for Inventory.
  • Biggest five-year swings in Inventory: soared 59.24% in 2021 and later plummeted 31.58% in 2022.
  • Year by year, Inventory stood at $54.3 million in 2021, then plummeted by 31.58% to $37.1 million in 2022, then skyrocketed by 30.07% to $48.3 million in 2023, then rose by 1.74% to $49.2 million in 2024, then grew by 10.61% to $54.4 million in 2025.
  • Business Quant data shows Inventory for SHC at $54.4 million in Q4 2025, $49.9 million in Q3 2025, and $59.9 million in Q2 2025.